IndieBio

IndieBio, founded in 2014, is a leading accelerator and venture capital firm focusing on early-stage biotech companies. It operates under SOSV, a global venture capital firm with over $1.5 billion in assets under management. IndieBio provides startups with an initial investment of up to $525,000, followed by continued support throughout subsequent funding rounds, deploying 80% of its capital post-program​. IndieBio has two main locations in San Francisco and New York, supporting a wide range of biotech innovations. Its portfolio includes companies like Upside Foods, NotCo, and Prellis Biologics, which are working on cutting-edge solutions in food tech, AI-driven product development, and 3D bioprinting, respectively. IndieBio emphasizes a diverse and inclusive environment, working with founders from various backgrounds and nationalities. The program is designed to help founders from the earliest stages, including pre-seed and seed, through Series A, by providing access to a robust network of mentors, industry experts, and co-investors​.